|
GB0029545D0
|
|
Process for producing 1,2,3,4 tetrahydroquinoline compounds
|
|
GB0018086D0
|
|
Chemical compound
|
|
GB0003028D0
|
|
Chemical compound
|
|
GB9930361D0
|
|
Chemical compound
|
|
GB9929038D0
|
|
Heterocyclic derivatives
|
|
GB9929037D0
|
|
Heterocyclic derivatives
|
|
GB9917290D0
|
|
Pharmaceutical composition
|
|
GB9916210D0
|
|
Pharmaceutical composition
|
|
GB9907004D0
|
|
Chemical compound
|
|
GB9812403D0
|
|
Heterocyclic compounds
|
|
GB9812408D0
|
|
Heterocyclic compounds
|
|
GB9812410D0
|
|
Heterocyclic derivatives
|
|
GB9812411D0
|
|
Hetrocyclic derivatives
|
|
GB9809694D0
|
|
Isomerisation process
|
|
GB9809692D0
|
|
A process for the preparation of cyclohexane derivatives
|
|
CZ340599A3
|
|
Derivative of quinoline-2-carboxylic acid
|
|
CZ314799A3
|
|
Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidenemethyl)-1H-indole-2-carboxylic acid
|
|
CN1242773A
|
|
Ticyclic carbapenem compound
|
|
US5849907A
|
|
Chemical process
|
|
GB9716961D0
|
|
Chemical compounds
|
